Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We’ll see ... we know LL is far much better than Resdesivir et al.
The crisis demand expediency. We have thousands of placebo patients dying everyday. We know what happens in one arm already.
Do we even know if the hospitals have signed off on data yet for M/M? Likely not.
As am I, hold for gold.
Yes, that one. The one you are trading on and determines your profit margins.
... and when is that? Those in the know say 7/22 not today.
Potentially yes. But the market is impatient and so goes the price.
If FDA blocks CYDY on Covid then sell to Mexico and world with no inhibitions. Leave the USA behind... sorry US citizens... have a revolution again. Helps having an Iranian CEO at that point.
What worldwide agencies could they leverage? WHO?
7/22 is likely based on those in the know here. It can drop plenty between then and now.
Keeps dropping as hope fades on pdufa date. Bad idea by CEO saying he might get it today. Under promise/over deliver.
Could fall to pre-Covid hype if FDA locks us out. That would suck. Is that 0.30 or 1.00?
Maybe, he’ll get canned if proven so. That would be positive news for profitability. Arnold wouldn’t be too pleased.
Nasdaq listing will be threatened soon again, then another R/S.
Good luck, shitty stock. Too much pumping from CEO.
True, revenue has to be first.
That’s why this is overweight right now. Lots of hype priced in. $2bil market cap on no concrete FDA acceptance? Big gamble.
I’m of the opinion this was manipulated up to serve this purpose. Those in the know knew the market PPs signal was $10.
I watch L2 on many stocks all day long and I watch Sykes group live feed. Most of those guys are newbies and follow the herd. The cydy play was exploited by the big boys but not on Sykes alerts... it would have been too obvious then. Only the inside crowd got the info.
Happens on many stocks, price movements of 100s of % points but no real accum difference As it’s all the same buyer/seller. Casualties along the way in the panic in stop losses and scalpers.
It’s a shame we all can’t play by the same rules, but when there’s no law that’s what happens.
It’ll be a slow news cycle until 7/22. I don’t think the FDA recognizes today at the PDUFA deadline since the additional requested material was sent later.
It could drop to 3ish in the meantime, especially if NP has fluff updates. Shorts love fluff news cycles.
Chas was about to get scammed IMO. Good thing this board was alerted to it by Gitreal.
No word yet on possible Chas meeting.
Spot on 100% here...
Yep. It’ll be quiet for awhile and AF/shorts can make up all kinds of crap between now and real news.
Predictable, let her drop. I’ll load up over next two weeks.
If Covid data sucks... then I’ll really load up.
Yep, he’s been here before. Get on the train or get off he doesn’t care.
He also doesn’t seem to care about Covid approval as it’s not his primary indication.
Frankly Covid is temporary but a great moneymaker. I think we could get a very small piece of the pie. Not the valuation we’re looking for.
Keep in mind that Rantes was only elevated in 50% of the SARS patients in Canada. I think leronlimab does better in phase 3 than 2.
Yeah but that won’t reach the market and I get the feeling longs aren’t going to chase. Need new buyers to chase and that requires content to share or a PR.
Going weak into PC. I see some selling and shorting.
Profitly guys are good at chart patterns before and after catalysts.
I still say this sees $3ish before FDA approval.
Hmm... no news, no halt, must be an update with a long Q&A.
NP just keeping the fire hot.
Nope, but I’m looking to buy if it dips.
Changes with the wind....
I had thought about that but how about this.
VYST WILL NEVER GET TO $2 PPS in 2020 (Without a RS)!
Opening could be rough... it’s up early but could crash at the bell.
I think we all need to be mentally prepared that leronlimab won’t be as graciously accepted by the FDA as we think it should be. I’ve already taken profits off the top as I believe the process will be tougher than most think. The otc pinks don’t have much patience, if the shorts continue to win it will test the resolve of long positions in the face of adversity.
Hmmm... I mention Vystar won’t tweet about Ema case and Boom it happens? Coincidence? Happy to see some updates
Gonna get ugly... right up until it can’t anymore. We will get to see just how powerful BP is in manipulating SP through fear and intimidation.
My bet is they know Finra is watching so they will be careful, yet surprisingly effective. Sykes group doesn’t give a shit, if there are shares to be borrowed they will short this all day long win or lose. Today they tried to play the opening bounce long but it was weak (Their take) so the shorting volume was down a little. Tomorrow if the presser is just chatter and they know an AS increase is pending they’ll keep coming back to eat. We’ve got 2-6 more weeks of this crap. Once revenues hit it gets easier.
Tomorrow is likely/simply going to be a timeline rundown by Scott Kelly about future FDA dates. I know NP says he doesn’t care about SP but that’s not entirely true, he told the banks and BOD that he didn’t need to dilute now and raise funds while the iron was hot. The SP does matter to the BOD and to uplisting.
The shorts are the worst at open if NO Pr, NP tried the gay monkey study and that didn’t work so now he’s trying this. Doesn’t matter, he needs FDA actionable events to get more market attention. The longs that are here can’t support millions of shares being sold short every day. He needs to justify a larger market cap, plus they are voting on an AS increase. The shorts know when the data is likely due and they have pending dilution... not good for SP.
Between now and likely 7/22 we will see a lot of bear raids and negative attacks. The SP will drop and test your will to hold. Buy what you can. Once FDA sees data then it’s over but we may have to wait for phase 3 to conclude. I see more stop losses getting taken and I don’t blame people for Leaving looking for a lower entry point reset.
This could get really ugly and AF fired the first prelude to the attack today. I hope I’m wrong.
I agree with all of that...
Yep, agreed. I do recall somewhere along the way someone posted Greg saying he couldn’t PR anything until EMA was resolved per guidance of lawyers... I’m not going to dig for that post. However, it would line up with the way this company operates. Rookie pubco and all...
The other PRs he puts out are mostly fluff that wouldn’t get him in trouble from the BOD.
Seems as though the anxiety of money crunch may force them to release real news before end of EMA case. If EMA would have to buy back in open market after a positive RXAir material event that would be painful.
Considering they are leveraging future sales at Rotmans they don’t have anything to say just yet. Their actions do not display confidence in future or past revenues.
My engineering pal got a response from Stephen Saunders. He said he would try and arrange a discussion with Chas.
This guy is very direct and can apply pressure to succeed. If Chas has done nothing he’ll know quickly. Of course If Chas doesn’t agree to meet then so be it, writing is on the wall then.
Greg is contracted by the company. Much easier to cut loose and I’m sure the BOD is recommending that. He’s got his shares as a golden parachute.
Right, but does Vystar know that? Likely not, considering their behavior to date.
It is ... that’s what I meant by HIV commercialization.
Uplist won’t help PPs much comparatively. But it will stop massive drops and shorting on the downtick.
Funny thing is that it IS subscription based if you don’t have Amazon Fire stick. $3.99/month. Also, you have to be a Prime member to even get access to channel.
They will make money, the 100% ad-based is misleading. The ads are very annoying but no more than commercials and they can be skipped.
I’d bet they won’t move until FDA approves Covid indication. Otherwise they run risk of falling out of qualification.
HIV commercialization could be a uplist catalyst as well.
Gotta have some kind of revenue established.
Yep, but’s it’s the accumulation that matters, not the churn. VYST is 264 million (right now) up since 52 week low.
Something is up, either flippers or insiders and what ratio?
I’m not a pubco lawyer, so I can’t speak to that but it’s been my experience that lawyers want silence in any material events until the case is settled. VYST IR is just fluffing ambiguously until then and also using rumors/leaks to prop up.
I have a feeling that VYST is starting to get financially anxious and will break loose on PRs soon.
Just a feeling from the tea leaves
Holding and watching. It’s always the darkest before dawn.